vs
AVANOS MEDICAL, INC.（AVNS）とRanger Energy Services, Inc.（RNGR）の財務データ比較。上の社名をクリックして会社を切り替えられます
AVANOS MEDICAL, INC.の直近四半期売上が大きい（$180.9M vs $142.2M、Ranger Energy Services, Inc.の約1.3倍）。Ranger Energy Services, Inc.の純利益率が高く（2.3% vs -0.7%、差は3.0%）。AVANOS MEDICAL, INC.の前年同期比売上増加率が高い（0.7% vs -0.6%）。AVANOS MEDICAL, INC.の直近四半期フリーキャッシュフローが多い（$21.3M vs $17.1M）。過去8四半期でAVANOS MEDICAL, INC.の売上複合成長率が高い（4.4% vs 1.9%）
Avanos Medicalは医療テクノロジー企業で、臨床医療機器の開発・製造に注力しており、疼痛管理と慢性ケアの2つのコア事業を展開しています。患者の回復促進や感染予防に取り組みながら、治療におけるオピオイド系薬剤の使用削減を目指しています。
レンジャー・エナジー・サービシズ社は北米屈指の陸上油田サービスプロバイダーであり、上流の石油・ガス事業者に対して坑井完成、修井、リグ運用、生産性向上ソリューションを提供し、主に米国本土のシェール・緻密資源開発地域で事業を展開しています。
AVNS vs RNGR — 直接比較
損益計算書 — Q4 FY2025 vs Q4 FY2025
| 指標 | | |
|---|---|---|
| 売上 | $180.9M | $142.2M |
| 純利益 | $-1.3M | $3.2M |
| 粗利率 | 47.5% | — |
| 営業利益率 | 1.4% | 2.3% |
| 純利益率 | -0.7% | 2.3% |
| 売上前年比 | 0.7% | -0.6% |
| 純利益前年比 | 99.7% | -44.8% |
| EPS（希薄化後） | $-0.02 | $0.14 |
緑 = その指標でリード。会計年度がずれている場合は期間が異なる場合あり
8四半期 売上・利益トレンド
並べて比較する四半期履歴。決算期がずれていても暦四半期で整列
| Q4 25 | $180.9M | $142.2M | ||
| Q3 25 | $177.8M | $128.9M | ||
| Q2 25 | $175.0M | $140.6M | ||
| Q1 25 | $167.5M | $135.2M | ||
| Q4 24 | $179.6M | $143.1M | ||
| Q3 24 | $170.4M | $153.0M | ||
| Q2 24 | $171.7M | $138.1M | ||
| Q1 24 | $166.1M | $136.9M |
| Q4 25 | $-1.3M | $3.2M | ||
| Q3 25 | $-1.4M | $1.2M | ||
| Q2 25 | $-76.8M | $7.3M | ||
| Q1 25 | $6.6M | $600.0K | ||
| Q4 24 | $-397.3M | $5.8M | ||
| Q3 24 | $4.3M | $8.7M | ||
| Q2 24 | $1.8M | $4.7M | ||
| Q1 24 | $-900.0K | $-800.0K |
| Q4 25 | 47.5% | — | ||
| Q3 25 | 48.4% | — | ||
| Q2 25 | 52.6% | — | ||
| Q1 25 | 53.6% | — | ||
| Q4 24 | 54.6% | — | ||
| Q3 24 | 54.5% | — | ||
| Q2 24 | 55.7% | — | ||
| Q1 24 | 57.1% | — |
| Q4 25 | 1.4% | 2.3% | ||
| Q3 25 | 0.1% | 2.0% | ||
| Q2 25 | -42.6% | 6.1% | ||
| Q1 25 | 6.1% | 0.7% | ||
| Q4 24 | -233.0% | 6.2% | ||
| Q3 24 | 7.0% | 8.4% | ||
| Q2 24 | 3.7% | 5.3% | ||
| Q1 24 | 2.4% | -0.4% |
| Q4 25 | -0.7% | 2.3% | ||
| Q3 25 | -0.8% | 0.9% | ||
| Q2 25 | -43.9% | 5.2% | ||
| Q1 25 | 3.9% | 0.4% | ||
| Q4 24 | -221.2% | 4.1% | ||
| Q3 24 | 2.5% | 5.7% | ||
| Q2 24 | 1.0% | 3.4% | ||
| Q1 24 | -0.5% | -0.6% |
| Q4 25 | $-0.02 | $0.14 | ||
| Q3 25 | $-0.03 | $0.05 | ||
| Q2 25 | $-1.66 | $0.32 | ||
| Q1 25 | $0.14 | $0.03 | ||
| Q4 24 | $-8.64 | $0.24 | ||
| Q3 24 | $0.09 | $0.39 | ||
| Q2 24 | $0.04 | $0.21 | ||
| Q1 24 | $-0.02 | $-0.03 |
貸借対照表と財務力
直近四半期の流動性・レバレッジ・純資産のスナップショット
| 指標 | | |
|---|---|---|
| 現金・短期投資手元流動性 | $89.8M | $10.3M |
| 総負債低いほど良い | $90.3M | — |
| 株主資本純資産 | $778.2M | $300.1M |
| 総資産 | $1.1B | $419.3M |
| 負債/資本比率低いほどレバレッジが低い | 0.12× | — |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $89.8M | $10.3M | ||
| Q3 25 | $70.5M | $45.2M | ||
| Q2 25 | $90.3M | $48.9M | ||
| Q1 25 | $97.0M | $40.3M | ||
| Q4 24 | $107.7M | $40.9M | ||
| Q3 24 | $89.0M | $14.8M | ||
| Q2 24 | $92.2M | $8.7M | ||
| Q1 24 | $75.8M | $11.1M |
| Q4 25 | $90.3M | — | ||
| Q3 25 | $93.4M | — | ||
| Q2 25 | $95.7M | — | ||
| Q1 25 | $98.0M | — | ||
| Q4 24 | $125.3M | $0 | ||
| Q3 24 | $152.6M | $0 | ||
| Q2 24 | $164.9M | $0 | ||
| Q1 24 | $167.2M | $0 |
| Q4 25 | $778.2M | $300.1M | ||
| Q3 25 | $778.0M | $270.0M | ||
| Q2 25 | $776.3M | $276.9M | ||
| Q1 25 | $839.4M | $272.6M | ||
| Q4 24 | $828.5M | $273.8M | ||
| Q3 24 | $1.2B | $267.6M | ||
| Q2 24 | $1.2B | $260.5M | ||
| Q1 24 | $1.2B | $261.7M |
| Q4 25 | $1.1B | $419.3M | ||
| Q3 25 | $1.1B | $372.8M | ||
| Q2 25 | $1.0B | $381.7M | ||
| Q1 25 | $1.1B | $376.5M | ||
| Q4 24 | $1.2B | $381.6M | ||
| Q3 24 | $1.7B | $373.9M | ||
| Q2 24 | $1.7B | $359.6M | ||
| Q1 24 | $1.7B | $355.5M |
| Q4 25 | 0.12× | — | ||
| Q3 25 | 0.12× | — | ||
| Q2 25 | 0.12× | — | ||
| Q1 25 | 0.12× | — | ||
| Q4 24 | 0.15× | 0.00× | ||
| Q3 24 | 0.12× | 0.00× | ||
| Q2 24 | 0.13× | 0.00× | ||
| Q1 24 | 0.14× | 0.00× |
キャッシュフローと資本効率
再投資後に実際に生み出すキャッシュ。純利益より操作が難しい
| 指標 | | |
|---|---|---|
| 営業キャッシュフロー直近四半期 | $28.2M | $24.1M |
| フリーキャッシュフロー営業CF - 設備投資 | $21.3M | $17.1M |
| FCFマージンFCF / 売上 | 11.8% | 12.0% |
| 設備投資強度設備投資 / 売上 | 3.8% | 4.9% |
| キャッシュ転換率営業CF / 純利益 | — | 7.53× |
| 直近12ヶ月FCF直近4四半期 | $43.1M | $42.9M |
8四半期トレンド — 暦四半期で整列
| Q4 25 | $28.2M | $24.1M | ||
| Q3 25 | $14.0M | $13.6M | ||
| Q2 25 | $6.8M | $20.7M | ||
| Q1 25 | $25.7M | $10.6M | ||
| Q4 24 | $57.9M | $32.7M | ||
| Q3 24 | $23.0M | $17.7M | ||
| Q2 24 | $27.8M | $22.1M | ||
| Q1 24 | $-8.0M | $12.0M |
| Q4 25 | $21.3M | $17.1M | ||
| Q3 25 | $7.0M | $8.0M | ||
| Q2 25 | $-4.2M | $14.4M | ||
| Q1 25 | $19.0M | $3.4M | ||
| Q4 24 | $53.1M | $27.3M | ||
| Q3 24 | $20.0M | $10.8M | ||
| Q2 24 | $21.9M | $6.8M | ||
| Q1 24 | $-12.1M | $5.5M |
| Q4 25 | 11.8% | 12.0% | ||
| Q3 25 | 3.9% | 6.2% | ||
| Q2 25 | -2.4% | 10.2% | ||
| Q1 25 | 11.3% | 2.5% | ||
| Q4 24 | 29.6% | 19.1% | ||
| Q3 24 | 11.7% | 7.1% | ||
| Q2 24 | 12.8% | 4.9% | ||
| Q1 24 | -7.3% | 4.0% |
| Q4 25 | 3.8% | 4.9% | ||
| Q3 25 | 3.9% | 4.3% | ||
| Q2 25 | 6.3% | 4.5% | ||
| Q1 25 | 4.0% | 5.3% | ||
| Q4 24 | 2.7% | 3.8% | ||
| Q3 24 | 1.8% | 4.5% | ||
| Q2 24 | 3.4% | 11.1% | ||
| Q1 24 | 2.5% | 4.7% |
| Q4 25 | — | 7.53× | ||
| Q3 25 | — | 11.33× | ||
| Q2 25 | — | 2.84× | ||
| Q1 25 | 3.89× | 17.67× | ||
| Q4 24 | — | 5.64× | ||
| Q3 24 | 5.35× | 2.03× | ||
| Q2 24 | 15.44× | 4.70× | ||
| Q1 24 | — | — |
財務フロー比較
売上 → 粗利 → 営業利益 → 純利益のサンキー図
セグメント別売上内訳
AVNS
| Enteral Feeding | $83.0M | 46% |
| Radiofrequency Ablation | $36.9M | 20% |
| Neonate Solutions | $32.1M | 18% |
| Surgical Pain And Recovery | $24.7M | 14% |
| Corporate Other | $4.2M | 2% |
RNGR
| High Specification Rigs | $92.3M | 65% |
| Processing Solutions And Ancillary Services | $37.5M | 26% |
| Wireline Services | $12.4M | 9% |
